Literature DB >> 17235509

Ionic dialysance: a new valid parameter for quantification of dialysis efficiency in acute renal failure?

Christophe Ridel1, David Osman, Lucile Mercadal, Nadia Anguel, Thierry Petitclerc, Christian Richard, Christophe Vinsonneau.   

Abstract

OBJECTIVE: Several studies have reported a close relationship between an increased dose of dialysis and survival in patients treated for acute renal failure. Unfortunately, the quantification of dialysis in critically ill patients based on the urea nitrogen formula Kt/V is not applicable. Ionic dialysance is a new parameter calculated in real time from the dialysate conductivity and correlated with the effective urea clearance in chronic hemodialysis patients. The aim of our study was to evaluate ionic dialysance in the quantification of dialysis in critically ill patients with acute renal failure.
DESIGN: Prospective open-label study.
SETTING: An 18-bed medical intensive care unit. PATIENTS: Thirty-one patients with multiple organ dysfunction syndrome and acute renal failure requiring intermittent hemodialysis were included. MEASUREMENTS: Using the first dialysis session of each patient, we compared the delivered dose of dialysis based on ionic dialysance measurement (Kt(ID)) with the well-accepted gold standard method based on fractional dialysate sampling (Kt(dialysate)). The data were analyzed using linear regression and Bland-Altman analysis.
RESULTS: Thirty-one intermittent hemodialysis sessions were performed in 31 critically ill patients (mean age 58+/-12 years, SAPS II score 56+/-10). We found a close correlation between Kt(dialysate) and Kt(ID) (Kt(dialysate) = 36.3+/-11.4 l; Kt(ID)=38.4+/-11.8; r=0.96) with excellent limits of agreement (-2.2 l; 6.4 l).
CONCLUSION: The feasibility of dialysis quantification based on ionic dialysance in the critically ill patient is good. This method is a simple and accurate tool for the determination of dialysis dose in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235509     DOI: 10.1007/s00134-006-0514-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  28 in total

1.  Ionic dialysance vs urea clearance in the absence of cardiopulmonary recirculation.

Authors:  Lucile Mercadal; Sophie Tézenas Du Montcel; Marie-Chantal Jaudon; Abdelaziz Hamani; Hassane Izzedine; Gilbert Deray; Bernard Béné; Thierry Petitclerc
Journal:  Nephrol Dial Transplant       Date:  2002-01       Impact factor: 5.992

2.  Daily hemodialysis and the outcome of acute renal failure.

Authors:  Helmut Schiffl; Susanne M Lang; Rainald Fischer
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

Review 3.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

4.  Accuracy and safety of online clearance monitoring based on conductivity variation.

Authors:  U Kuhlmann; R Goldau; N Samadi; T Graf; M Gross; G Orlandini; H Lange
Journal:  Nephrol Dial Transplant       Date:  2001-05       Impact factor: 5.992

5.  Determination of the solute removal index for urea by using a partial spent dialysate collection method.

Authors:  Y L Cheng; C C Shek; F K Wong; K S Choi; K F Chau; T S Ing; C S Li
Journal:  Am J Kidney Dis       Date:  1998-06       Impact factor: 8.860

6.  NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation.

Authors: 
Journal:  Am J Kidney Dis       Date:  1997-09       Impact factor: 8.860

7.  Regression analysis.

Authors:  J M Bland; D J Altman
Journal:  Lancet       Date:  1986-04-19       Impact factor: 79.321

8.  Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey.

Authors:  Claude Guérin; Raphaele Girard; Jean Marc Selli; Louis Ayzac
Journal:  Intensive Care Med       Date:  2002-08-17       Impact factor: 17.440

9.  Prescribed versus delivered dialysis in acute renal failure patients.

Authors:  J A Evanson; J Himmelfarb; R Wingard; S Knights; Y Shyr; G Schulman; T A Ikizler; R M Hakim
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

10.  Urea space and total body water measurements by stable isotopes in patients with acute renal failure.

Authors:  T Alp Ikizler; M Tugrul Sezer; Paul J Flakoll; Sree Hariachar; N Suren Kanagasundaram; Nancy Gritter; Stephanie Knights; Yu Shyr; Emil Paganini; Raymond M Hakim; Jonathan Himmelfarb
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

View more
  3 in total

1.  Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study.

Authors:  Christophe Leroy; Bruno Pereira; Edouard Soum; Claire Bachelier; Elisabeth Coupez; Laure Calvet; Konstantinos Bachoumas; Claire Dupuis; Bertrand Souweine; Alexandre Lautrette
Journal:  Ann Intensive Care       Date:  2021-01-22       Impact factor: 6.925

2.  How to deal with dialysis catheters in the ICU setting.

Authors:  Natacha Mrozek; Alexandre Lautrette; Jean-François Timsit; Bertrand Souweine
Journal:  Ann Intensive Care       Date:  2012-11-23       Impact factor: 6.925

Review 3.  Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-01-04       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.